EHA 2019: Clinical benefit of daratumumab plus standard of care in transplant-eligible NDMM patients

Phillippe Moreau | EHA 2019 | Juni 17, 2019

Speaker: Phillippe Moreau

Click and hear Philippe Moreau present the data from CASSIOPEIA study - the first study to demonstrate the clinical benefit of daratumumab plus standard of care in transplant-eligible NDMM patients.